InsidersTradesSigma
Browse the complete record of transactions filed by KISNER DANIEL L, Director. Officer active across 1 companies, notably Zynerba Pharmaceuticals, Inc.. Cumulatively, 3 filings have been published. The latest transaction was disclosed on 14 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
3 of 3 declarations
Daniel L. Kisner is a Board Member at Zynerba Pharmaceuticals, Inc. He is involved in governance and strategic decision-making. With expertise in the pharmaceutical sector, Daniel contributes to innovation and growth within the company.